Evolent Health (EVH) Tops Q3 EPS by 50c

Evolent Health (NYSE: EVH) reported Q3 EPS of $0.62, $0.50 better than the analyst estimate of $0.12. Revenue for the quarter came in at $352.6 million versus the consensus estimate of $357.32 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does